McKesson | MCK - Cash And Equivalent

Stock Price
760.57
Daily Change
13.34 1.79%
Monthly
-12.31%
Yearly
5.03%
Q2 Forecast
745.28

McKesson reported $3.98B in Cash and Equivalent for its fiscal quarter ending in March of 2026.





Cash And Equivalent Change Date
Acadia Healthcare USD 158.47M 25.23M Mar/2026
Align Technology USD 1.06B 35.07M Mar/2026
Cardinal Health USD 3.94B 1.16B Mar/2026
Centene USD 21.26B 3.38B Mar/2026
Charles River Laboratories USD 191.83M 21.94M Mar/2026
Cigna USD 7.04B 636M Mar/2026
Community Health Systems USD 712M 452M Mar/2026
Computer Programs Systems USD 24.85M 4.93M Dec/2025
CVS Health USD 9.54B 1.09B Mar/2026
DaVita Healthcare Partners USD 644.24M 32.2M Mar/2026
Dentsply International USD 190M 136M Mar/2026
eHealth USD 63.09M 2.83M Sep/2025
Elevance Health USD 9.66B 166M Mar/2026
Encompass Health USD 110.5M 38.3M Mar/2026
HCA USD 940M 100M Mar/2026
Henry Schein USD 138M 18M Mar/2026
Humana USD 4.95B 751M Mar/2026
IQVIA Holdings USD 1.95B 33M Mar/2026
J&J USD 21.69B 1.98B Mar/2026
Laboratory Of America USD 981.1M 448.8M Mar/2026
McKesson USD 3.98B 1.02B Mar/2026
Molina Healthcare USD 5.31B 1.07B Mar/2026
Owens Minor USD 336.88M 54.89M Mar/2026
Quest Diagnostics USD 393M 27M Mar/2026
Stryker USD 2.88B 1.13B Mar/2026
Tenet Healthcare USD 2.97B 84M Mar/2026
UnitedHealth USD 31.23B 3.11B Mar/2026
Universal Health Services USD 119.03M 18.77M Mar/2026
Veradigm USD 492.6M 7.57M Sep/2022